1 not yet recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Haic: new trials by email Literature Review of Haic trials Research Report on Haic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma FOLFOX regimen, Immunotherapy, targeted therapy - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | BinYong Liang | 100 | 2026-04-30 | 2026-04-13 |
| Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC Nocardia rubra cell wall skeleton, Hepatic arterial infusion chemotherapy, Lenvatinib - Hepatocellular Carcinoma | Phase 1 | Unknown | Wan-Guang Zhang | 30 | 2022-09-01 | 2023-12-19 |
BinYong Liang (1) · Wan-Guang Zhang (1)
China (1)